Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)
Novo Nordisk imposed a global hiring freeze for non-critical roles as new CEO Maziar Doustdar targets cost cuts amid slowing Wegovy sales and tighter margins. The company may cut sales staff and shift focus to new drugs to compete with Eli Lilly.
